Lv1
20 积分 2023-01-29 加入
T-cell death and cancer immune tolerance
2天前
已完结
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
3个月前
已完结
The diversity of CD8+ T cell dysfunction in cancer and viral infection
3个月前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
4个月前
已完结
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
9个月前
已完结
Deficiencies in the CD19 complex
1年前
已完结
Exploring the next generation of antibody–drug conjugates
1年前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1年前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
1年前
已完结
An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases
1年前
已完结
皖公网安备34019202002308
